SCHEMBL79099

SCHEMBL79099

C=Cc1cc2c(OC)c(OC)ccc2cc1OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.43
CYP3A4 P08684 3/20 0.43
TDO2 P48775 7/20 0.42
IDO1 P14902 6/20 0.42
CDC42 P60953 2/20 0.39
RAC1 P63000 2/20 0.39
CYP1A1 P04798 2/20 0.39
CYP1B1 Q16678 2/20 0.39
CYP1A2 P05177 1/20 0.39
MAOA P21397 2/20 0.38
KDM4E B2RXH2 3/20 0.38
ABL1 P00519 1/20 0.38
POLB P06746 1/20 0.38
GAA P10253 1/20 0.38
PKM P14618 1/20 0.38
APEX1 P27695 1/20 0.38
RECQL P46063 1/20 0.38
BLM P54132 1/20 0.38
CDK5 Q00535 1/20 0.38
MCL1 Q07820 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL81312 0.82 CYP3A4 (0.53) MAPTCYP3A4TDO2IDO1CDC42
SCHEMBL51194 0.77 CYP3A4 (0.45) MAPTCYP3A4TDO2IDO1CDC42
SCHEMBL8160228 0.77 TRPA1 (0.49) MAPTCYP3A4TDO2IDO1CDC42
SCHEMBL21255664 0.75 TUBB4A (0.51) MAPTCYP3A4TDO2IDO1CDC42
SCHEMBL7906421 0.75 CYP3A4 (0.43) MAPTCYP3A4TDO2IDO1CDC42
SCHEMBL50225 0.74 MAPT (0.47) MAPTCYP3A4TDO2IDO1CDC42
SCHEMBL2908216 0.73 MAOA (0.49) MAPTCYP1A1CYP1B1MAOAKDM4E
SCHEMBL15899630 0.73 ALDH1A1 (0.52) CYP3A4CYP1A1CYP1B1CYP1A2KDM4E
SCHEMBL8213905 0.73 CYP3A4 (0.48) MAPTCYP3A4CYP1A2MAOAKDM4E
SCHEMBL7928059 0.73 NQO1 (0.50) MAPTCYP1A1CYP1B1CYP1A2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8129530-B2 Catecholamine derivatives and prodrugs thereof H. LUNDBECK A/S (DK) 2012-03-06 US disclosed
US-20090062324-A1 CATECHOLAMINE DERIVATIVES AND PRODRUGS THEREOF H. LUNDBECK A/S (DK) 2009-03-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090062324-A1 CATECHOLAMINE DERIVATIVES AND PRODRUGS THEREOF COMT, ADRB3, ADRB1 MAPT 1508/4885CYP3A4 29/4885TDO2 243/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.